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Background: It is well known that suspension laryngoscopy (SL) produces marked hemodynamic changes. Coughing 
during extubation sometimes causes adverse clinical problems. We investigated whether 10% lidocaine spray could 
attenuate hemodynamic stress responses due to SL and reduce coughing incidence during extubation.
Methods: Sixty patients undergoing SL were randomly divided into two groups and intubated without 10% lidocaine 
spray (control group) or given 1.5 mg/kg of 10% lidocaine, sprayed onto laryngeal and intratracheal sites 2 min prior 
to intubation (10% lidocaine group). Mean arterial pressure (MAP) and heart rates (HR) during SL and coughing 
incidence during extubation were recorded.
Results: MAP at 2.5 and 5 min (P < 0.05) and HR at 2.5 min after SL (P < 0.01) were greater in the control group than 
in the 10% lidocaine group. The number of coughs decreased in the 10% lidocaine group compared to the control 
group during pre- (6.8 ± 3.2 vs 10.3 ± 4.4, P < 0.01) and post-extubation period of 5 min (4.0 ± 2.3 vs 6.2 ± 4.2, P < 0.05) 
and during the entire study period (10.8 ± 3.9 vs 16.5 ± 5.6, P < 0.001).
Conclusions: Preoperative laryngeal and intratracheal spraying with 1.5 mg/kg of 10% lidocaine spray is effective for 
attenuation of arterial pressure increase to SL and suppression of coughing during extubation. (Korean J Anesthesiol 
2011; 60: 422-427)
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Introduction
    Suspension laryngoscopy during laryngeal microscopic 
surgery for diagnosis or treatment of upper airway disorders 
may directly produce pressure stimulation on the laryngeal 
tissue. This causes marked cardiovascular responses via 
irritation of the deep sensory receptors of the larynx [1,2]. An 
increase of arterial pressure and heart rate caused by suspension 
laryngoscopy are usually temporary and rarely accompanied by 
sequelae [3]. Nevertheless, constant intraoperative vigilance is 
necessary because such increases can be fatal in patients who 
have hypertension, myocardial ischemia or cerebrovascular 
disease.
    Coughing due to airway irritation during extubation can cause 
harmful effects such as hypertension, tachycardia, arrhythmia, 
myocardial ischemia, bronchospasm, bleeding at operative site, 
intracranial and intraocular hypertension [4,5]. Moreover, the 
likelihood of postoperative coughing can increase in laryngeal 
microscopic surgery in which the stimulus of surgical and 
suspension laryngeal manipulation is largely concentrated on 
the larynx or vocal cord.
    Lidocaine administered to the larynx or trachea is known to 
be effective in suppressing blood pressure increase caused by 
intubation [6,7] and is also known for blocking cardiovascular 
responses to airway irritation [8,9]. We therefore hypothesized 
that 10% lidocaine spray may be helpful in attenuating the 
irritation caused by suspension laryngoscopy and extubation. 
In this study, we investigated the effects of preoperative 10% 
lidocaine spray on hemodynamic changes and coughing 
responses during suspension laryngoscopy and extubation 
under general anesthesia.
Materials and Methods
    After obtaining institutional review board approval and 
informed consent from patients, 60 American Society of 
Anesthesiologists physical status I patients between the ages 
of 20-65 scheduled for laryngeal microscopic surgery with 
suspension laryngoscopy were included in this study.
    Patients with the following conditions were excluded from the 
study: cardiovascular diseases, hypertension, diabetes mellitus, 
respiratory disease, recent history of respiratory infection, a 
known hypersensitivity to lidocaine, Cormack & Lehane Class 
3 or 4, patients who were expected to have difficult intubation 
or patients who received antihypertensive drug due to an 
exaggerated hypertensive response during surgery.
    Patients were randomly divided into a control group (n = 30) 
and a 10% lidocaine group (n = 30). In both groups, patients 
were premedicated with glycopyrrolate 0.2 mg intramuscularly 
1 hr before surgery. Pentothal sodium 4 mg/kg and alfentanil 
15 μg/kg were intravenously administered for anesthetic 
induction. In case of adequate ventilation, rocuronium bromide 
0.6 mg/kg was administered as muscle relaxants. Two min 
after the administration of muscle relaxants, patients from the 
control group were intubated with no treatment, whereas for 
patients in the 10% lidocaine group, after checking the Cormack 
& Lehane Classification under direct vision with a Macintosh 
laryngoscope, the trachea was sprayed using 1.5 mg/kg of 10% 
lidocaine spray (Xylocaine 10% spray, AstraZeneca, Korea). Fifty 
percent of total dose was sprayed on the larynx and epiglottic 
area and the other 50% in the trachea. This was followed by 
immediate endotracheal intubation. During the anesthesia, 
standard monitoring devices (Multi Channel Anesthesia 
Monitor S/5, Datex-ohmeda, Beaverton, Oregon, USA) were 
applied to measure electrocardiography, noninvasive blood 
pressure, heart rate, pulse oximetry, capnography, and end-
tidal sevoflurane concentration. Anesthesia was maintained 
with 2.0% end-tidal sevoflurane and O2/N2O 1.5/1.5 L/min. 
Using a bispectral index (BIS) monitor (A-2000 BIS
Ⓡ Monitor 
System; Aspect Medical Systems, Newton, Messachusetts, USA) 
BIS values were maintained by 40-60 by adjusting 0.5 vol% of 
sevoflurane each time. Ventilation of the lungs was adjusted to 
maintain an end-tidal carbon dioxide of 30-35 mmHg.
    Upon arriving at the operating room, before anesthetic 
induction, arterial blood pressure and heart rate were measured 
at a stable state as baseline values. After intubation, suspension 
laryngoscopy was undertaken in both groups after waiting until 
arterial blood pressures and heart rates returned to the baseline 
values. Arterial blood pressures and heart rates were measured 
immediately before suspension laryngoscopy, at 2.5 min, 5 
min and 10 min after suspension laryngoscopy. Sevoflurane 
and N2O administration were immediately discontinued after 
withdrawal of suspension laryngoscopy, and subjects were 
then ventilated with 100% O2 at 5 L/min. Glycopyrrolate and 
pyridostigmine were administered intravenously to reverse 
muscle relaxation if the TOF responses > 2. At 5 min after 
reversing muscle relaxation, tracheal tubes were removed 
when the TOF ratio (T4/T1) was > 0.7. If TOF ratio was < 0.7, 
extubation was delayed and the patient was excluded from 
study. Number of coughs and rating of coughing per patient 
from 5 min before extubation to immediately before extubation 
and from immediately after extubation to 5 min after extubation 
were recorded. Arterial blood pressures and heart rates were 
measured 5 min before extubation, 2.5 min before extubation, 
immediately before extubation, immediately after extubation, at 
2.5 min and 5 min after extubation. All data were recorded by an 
anesthesiologist unaware of study protocol and patient groups. 
Side effects were investigated the day after surgery.
    Statistical analysis was performed using SPSS
Ⓡ 17.0. software 
(SPSS Inc., Chicago, IL, USA). Between the groups, the demo-424 www.ekja.org
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graphic data, arterial blood pressure, heart rate and number 
of coughs were analyzed using an unpaired t test. Arterial 
blood pressures and heart rates of each group were analyzed 
using repeated measures of ANOVA. Nonparametric data were 
analyzed using chi-square test and Fisher's exact test. P < 0.05 
was considered significant.
Results
    Five patients were excluded from the analysis because of 
Cormack & Lehane Class 3 or 4 (one in the control group and 
one in the 10% lidocaine group), because of administration of 
antihypertensive drugs due to an exaggerated hypertensive 
response during surgery (two in the control group) or because 
the TOF ratio was < 0.7 5 min after reversing muscle relaxation 
(one in the 10% lidocaine group).
    No statistically significant differences were found between 
the two study groups with respect to demographic data, time of 
operation and anesthesia, or number of smokers (Table 1).
    As compared with baseline values, mean arterial pressure 
(MAP) and heart rates increased 2.5 min and 5 min after sus-
pen  sion laryngoscopy (P < 0.05), and no significant difference 
was observed at 10 min after suspension laryngoscopy in the 
two groups. However, MAP at 2.5 and 5 min after suspension 
laryngoscopy (P < 0.05) and heart rates 2.5 min after suspension 
laryngoscopy (P < 0.01) in the control group were significantly 
higher than in the 10% lidocaine group (Table 2).
    Number of coughs for 5 min before extubation (P < 0.01), for 
5 min after extubation (P < 0.05), and during the entire study 
period (P < 0.001) in the 10% lidocaine group were lower than 
in the control group (Table 3).
    MAP at 2.5 min before extubation (P < 0.05), immediately 
before extubation (P < 0.001), and immediately after extubation 
(P < 0.05) in the control group were significantly higher than 
in the 10% lidocaine group. Heart rate in the control group 
was higher than in the 10% lidocaine group 2.5 min before 
extubation (P < 0.05), immediately before extubation (P < 0.01), 
and 2.5 min after extubation (P < 0.05). As compared with 5 
min before extubation, MAP increased from 2.5 min before 
extubation to 2.5 min after extubation (P < 0.001) in the control 
group, and increased from 2.5 min before extubation to 2.5 min 
after extubation (P < 0.001) and at 5 min after extubation (P < 
0.01) in the 10% lidocaine group. In both groups, heart rates 
from 2.5 min before extubation to 2.5 min after extubation (P < 
0.05) higher than 5 min before extubation (Table 4).
    There were 5 patients with sorethroat and 2 patients with 
swallowing difficulty in the control group, and 6 patients with 
sorethroat and 2 patients with swallowing difficulty in the 10% 
Table 1. Characteristics of Patients  
Control group  
(n = 27)
10% lidocaine group 
(n = 28)
Age (yr)
Sex (M/F)
Height (cm)
Weight (kg)
Operating time (min)
Anesthesia time (min)
Number of smoker
  53.7 ± 5.9
18/9 
162.1 ± 4.7
  64.2 ± 7.8
  13.5 ± 6.5
  28.9 ± 7.2
10
  56.1 ± 4.5
16/12
160.5 ± 6.8
  63.4 ± 8.0
  14.1 ± 8.4
  30.1 ± 7.9
8
Values were expressed as mean ± SD or number.
Table 2. Mean Arterial Pressures and Heart Rates during Application of Suspension Laryngoscope 
T1 T2 T3 T4 T5
MAP (mmHg)
    Control group
    10% lidocaine group
HR (beats/min)
    Control group
    10% lidocaine group
88.9 ± 2.9
89.2 ± 3.1
76.6 ± 10.3
75.5 ± 7.4
92.1 ± 11.6
88.8 ± 8.9
84.4 ± 13.9
78.0 ± 14.0
117.7 ± 16.9
||
105.7 ± 15.6*,||
  105.3 ± 16.7
||
    91.0 ± 16.4
†,||
109.8 ± 10.1
||
100.9 ± 15.1*,§
 90.1 ± 13.1
§
 83.4 ± 15.2
‡
95.8 ± 10.2
89.5 ± 6.7
77.6 ± 10.5
81.3 ± 14.9
Values were expressed as mean ± SD. T1: pre-induction, T2: pre-application of suspension laryngoscope, T3: 2.5 min after suspension 
laryngoscope, T4: 5 min after suspension laryngoscope, T5: 10 min after suspension laryngoscope, MAP: mean arterial pressure, HR: heart rate. 
*P < 0.05, 
†P < 0.01 as compared with the control group and 
‡P < 0.05, 
§P < 0.01, 
||P < 0.001 as compared with pre-induction.
Table 3. Number of Coughs and Incidence of Coughing during Extu-
bation  
Control group 
(n = 27)
10% lidocaine 
group (n = 28)
I. Pre-extubation period of 5 min
     Number of coughs
     Incidence of coughing (%)
II. Post-extubation period of 5 min
     Number of coughs
     Incidence of coughing (%)
§
III. Period of  I + II
     Number of coughs
     Incidence of coughing (%)
  
10.3 ± 4.4
27/27 (100) 
  6.2 ± 4.2
25/27 (92.6) 
  16.5 ± 5.6
27/27 (100) 
 6.8 ± 3.2
†
23/28 (82.1) 
 4.0 ± 2.3*
19/28 (67.9) 
 10.8 ± 3.9
‡
23/28 (82.1) 
Values were expressed as mean ± SD or number. *P < 0.05, 
†P < 0.01, 
‡P < 0.001 as compared with the control group. 
§P < 0.05 between 
the control and 10% lidocaine groups.425 www.ekja.org
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lidocaine group. However, no significant inter-group difference 
was observed and no patient in either group was serious 
enough to require treatment (Table 5).
Discussion
    In the present study, 10% lidocaine sprayed on laryngeal and 
intratracheal site suppressed elevation of arterial blood pressure 
and heart rate caused by suspension laryngoscopy and also 
reduced occurrence of coughing caused by airway irritation 
during extubation.
    Airway irritation due to suspension laryngoscopy, in addition 
to surgical stimulation, accentuates the sympathetic nervous 
system and causes excessive elevation of arterial blood pressure 
and heart rate in laryngeal microscopic surgery. This can lead 
to complications, such as myocardial ischemia, myocardial 
infarction, and arrhythmia [1]. In one previous study, laryngeal 
microscopic surgery using suspension laryngoscopy had a 
higher rate of postoperative cardiac complications compared 
to other types of surgeries [3]. Thus, serious consideration 
by anesthesiologist should be given to the perioperative 
cardiovascular responses such as hypertension and tachycardia 
owing to suspension laryngoscopy. Opioids [10], α- and 
β-blockers [11], β-blockers [11] or α2 agonists [12] have been 
used, but these drugs should be used with care because 
of delays in postoperative awakening and occurrence of 
complications in decline of cardiac function. Time interval from 
spray to airway stimulation is important for lidocaine spray to 
be effective in reducing hemodynamic responses caused by 
airway irritation. Takita et al. [6] reported that studies regarding 
attenuation of noxious stimuli from endotracheal intubation at 
2 min after lidocaine spray [13] and no attenuation within 1 min 
after lidocaine spray [14], indicate that 2 or more time intervals 
from lidocaine administration to airway stimulation are needed 
to reduce the hemodynamic responses due to endotracheal 
intubation. In this study, it seems that the lidocaine onset time 
against the suspension laryngoscopic stimulation was sufficient 
because it was sprayed before endotracheal intubation, and the 
suspension laryngoscopy was performed after waiting until the 
patients had stable hemodynamics from the intubation.
    There have been several administration routes such as 
intravenous injection, endotracheal tube cuff or laryngotracheal 
instillation for lidocaine to prevent the occurrence of 
coughing caused from irritation during extubation. However, 
intravenous lidocaine injection during preextubation period 
may delay awakening from general anesthesia [15], and 
lidocaine administered into the endotracheal tube cuff can 
lead to a serious complication in case of rupture of cuff. Few 
studies have investigated the effects of 10% lidocaine spray 
on reducing postoperative coughing, although some studies 
have reported that laryngotracheal lidocaine administration 
was an effective way to prevent coughing [8,15-17]. Soltani and 
Aghadavoudi [18] compared postoperative coughing rates via 
various administration routes of lidocaine. They observed that 
10% lidocaine spray not only had a higher coughing incidence 
than administration of lidocaine into the endotracheal tube 
cuff or intravenous lidocaine injection at the end of surgery, 
but also had no difference compare to the control group. In 
their research, however, the lidocaine doses for each group 
were not the same, and the lidocaine dose in the 10% lidocaine 
spray group was 30 mg. When 1.5 mg/kg of lidocaine was 
sprayed in this study, the number of coughs for 5 min before 
and after extubation, and the incidence of coughing during 
5 min after extubation were significantly lower than in the 
control group. Also, the arterial blood pressures and heart rates 
in the 10% lidocaine group were sustained stably during the 
Table 4. Mean Arterial Pressures and Heart Rates during Extubation 
T1 T2 T3 T4 T5 T6
MAP (mmHg)
    Control group
    10% lidocaine group
HR (beats/min)
    Control group
    10% lidocaine group
101.5 ± 9.5
  96.8 ± 11.5
90.3 ± 15.0
83.6 ± 15.8
114.7 ± 10.2
¶
107.9 ± 11.7*,¶
105.3 ± 19.4
¶
  91.4 ± 16.4*,¶
117.3 ± 8.2
¶
108.8 ± 7.3
‡,¶
 108.9 ± 16.8
¶
  91.1 ± 18.7
†,|| 
118.2 ± 9.4
¶ 
111.6 ± 11.4*,¶
 103.8 ± 14.4
||
    96.0 ± 14.1
¶ 
 111.0 ± 7.7
¶
 106.9 ± 10.0
¶
 100.4 ± 14.9
§
   90.3 ± 15.4*,§
106.8 ± 9.6
102.7 ± 8.5
||
94.9 ± 14.0
88.0 ± 15.9
Values were expressed as mean ± SD. T1: 5 min before extubation, T2: 2.5 min before extubation, T3: immediately before extubation, T4: 
immediately after extubation, T5: 2.5 min after extubation, T6: 5 min after extubation, MAP: mean arterial pressure, HR: heart rate. *P < 0.05, 
†P < 0.01, 
‡P < 0.001 as compared with the control group and 
§P < 0.05, 
||P < 0.01, 
¶P < 0.001 as compared with T1.
Table 5. Comparison of Postoperative Complications     
Control group  
(n = 27)
10% lidocaine group 
(n = 28)
Sorethroat
Swallowing difficulty
Aspiration
Laryngospasm or  
  bronchospasm 
   5
   2
   0
   0 
  6
  2
  0
  0
Values were expressed as number.426 www.ekja.org
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extubation period than in the control group. Therefore, these 
results indicate that the 10% lidocaine spray can adequately 
block the circulatory responses and airway stimuli due to the 
endotracheal tube.
    The mechanism for attenuation of airway stimuli and hemo-
dynamic responses by locally administered lidocaine such as 
spray into the laryngotracheal site may be interpreted as an 
increase in blood concentration due to systemic absorption of 
lidocaine, or a topical local anesthetic effect. In case of intra-
venously administered lidocaine, cough reflex owing to airway 
stimulation during tracheal intubation or emergence was 
suppressed by plasma lidocaine concentration in excess of 3 
μg/ml [19,20]. However, plasma concentration of lidocaine 
administered in the trachea is generally lower than when 
administered intravenously [4,21,22], and intratracheal spray 
of 2.0 mg/kg of lidocaine prevented hyperdynamic circulatory 
responses due to endotracheal intubation even in plasma 
concentration of 1.5 μg/ml [23]. The 1.5 mg/kg of lidocaine 
sprayed in the present study is considered inadequate to reach 
3 μg/ml of plasma concentration. Accordingly, no increase 
in plasma concentration by systemic absorption of lidocaine 
but by topical local anesthetic effect is believed to suppress 
circulatory responses and coughing due to airway stimulation.
    Problems such as the occurrence of postoperative sorethroat 
should also be considered, although lidocaine spray before 
endotracheal intubation can be a useful method to attenuate 
airway irritation due to endotracheal tubes. With respect to 
postoperative sorethroat occurring due to lidocaine spray, there 
have been conflicting results in previous reports. Maruyama 
et al. [24] reported that when 8% lidocaine is sprayed before 
intubation, additives such as 1-menthol, ethanol, and alkalized 
solvents contained in lidocaine spray might add to the damage 
on the tracheal mucosa, thus leading to an increase in the 
incidence of postoperative sorethroat after total intravenous 
anesthesia. However, Herlevsen et al. [25] showed that there 
was no significant correlation between lidocaine spray and 
incidence of postoperative sorethroat. Klemola et al. [26] also 
reported that lidocaine spray itself did not play a significant 
role in the incidence of sorethroat, although the concomitant 
use of lidocaine spray and jelly increased postoperative 
sorethroat. Moreover, Oh et al. [27] reported that preoperative 
10% lidocaine spray to pharyngolaryngeal and intratracheal 
sites reduces the incidence of postoperative sorethroat. In the 
present study, 10% lidocaine spray did not cause any serious 
postoperative complications, and in contrast to the report by 
Maruyama et al. [24], we were able to show that the incidence 
of postoperative sorethroat did not increase from the use of 
lidocaine spray.
    In summary, we investigated the ability of 10% lidocaine 
spray to attenuate stimuli due to suspension laryngoscopy 
or extubation in patients undergoing laryngeal microscopic 
surgery with suspension laryngoscope. Our results show that 1.5 
mg/kg of 10% lidocaine preoperatively sprayed on laryngeal and 
intratracheal site not only effectively blocked cardiovascular 
responses due to suspension laryngoscopy but also suppressed 
coughing that follows extubation. These findings indicate that 
preoperative 10% lidocaine spray may be helpful in maintaining 
stable hemodynamics in laryngeal microscopic surgery with 
suspension laryngoscope.
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